Citigroup Maintains Neutral on WalkMe, Raises Price Target to $12
Citigroup analyst Tyler Radke maintains WalkMe (NASDAQ:WKME) with a Neutral and raises the price target from $11 to $12.
Wells Fargo Maintains Overweight on WalkMe, Raises Price Target to $13
Wells Fargo analyst Michael Turrin maintains WalkMe (NASDAQ:WKME) with a Overweight and raises the price target from $12 to $13.
WalkMe’s Focus On Enterprise Customer Will Drive Profitability, Analyst Says
Needham analyst Scott Berg reiterated a Buy On WalkMe Ltd (NASDAQ:WKME) with a $20 price target. WalkMe reported a solid 3Q22 with…
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
Earnings Scheduled For November 15, 2022
Companies Reporting Before The Bell
• Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 236 companies set new 52-week lows.
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers
Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.